CATO PHARMA ApS: Financial statements 2022
CVR: 33949596
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CATO PHARMA ApS (CVR 33949596) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -1,172 compared with DKK -614 the year before. Equity in the 2022 report amounted to DKK -282,112.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -1,172
- Equity
- DKK -282,112
- Total Assets
- DKK 2,242
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | 0 | -1 t. | -282 t. | - |
| 2021 | 0 | 0 | -614 | -281 t. | - |
| 2020 | 0 | 0 | -352 | -280 t. | - |
| 2019 | - | - | -588 | -280 t. | - |
| 2018 | - | - | -6 t. | -279 t. | - |
Official annual report
Keep an eye on CATO PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CATO PHARMA ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -614.
About CATO PHARMA ApS
CATO PHARMA ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2011. The company has been dissolved. The company was registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. In 2024, the company reported a net result of DKK -1,668 compared with DKK -1,588 the year before. Equity in the 2024 report amounted to DKK -283,700.